Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin. (Q51566044)

7 April 2018

title

Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin. (English)

1 reference

7 April 2018

0 references

Contacos C

1

1 reference

7 April 2018

Barter PJ

series ordinal

2

1 reference

7 April 2018

Vrga L

series ordinal

3

1 reference

7 April 2018

Sullivan DR

series ordinal

4

1 reference

7 April 2018

publication date

1 November 1998

1 reference

7 April 2018

published in

Atherosclerosis

1 reference

7 April 2018

volume

141

1 reference

7 April 2018

issue

1

1 reference

7 April 2018

page(s)

87-98

1 reference

7 April 2018

Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Effect of marine lipids on cholesteryl ester transfer and lipoprotein composition in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

A new in vitro method for the simultaneous evaluation of cholesteryl ester exchange and mass transfer between HDL and apoB-containing lipoprotein subspecies. Identification of preferential cholesteryl ester acceptors in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Differential effects of nicotinic acid in subjects with different LDL subclass patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Simvastatin-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low and low density lipoproteins in normolipidemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Pravastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Effects of postprandial lipemia on plasma cholesterol metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

A rapid flat gel isoelectric focusing method for the determination of apolipoprotein E phenotypes and its application.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Characterization of human high-density lipoproteins by gradient gel electrophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human Plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

Change in LDL particle size is associated with change in plasma triglyceride concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Alimentary lipemia-induced redistribution of cholesteryl ester between lipoproteins. Studies in normolipidemic, combined hyperlipidemic, and hypercholesterolemic men.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900151-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(98)00151-8

1 reference

7 April 2018

PubMed ID

9863541

1 reference

7 April 2018